Insider Trading History of Levine Mitchell S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Levine Mitchell S since 2008. This trader's CIK number is 1383492. At the time of last reporting, Levine Mitchell S was the Chief Financial Officer of Oncocyte Corp. (stock ticker symbol OCX). Also see all insider trading activities at Oncocyte Corp.

Note that in the past Levine Mitchell S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Oncocyte Corp (OCX) by Levine Mitchell S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 OCX 25,000 $29,149 0 $0 0 $0
2021 OCX 0 $0 0 $0 20,000 $0
2020 OCX 10,000 $13,200 0 $0 20,000 $0
2019 OCX 10,000 $20,059 0 $0 0 $0
2018 OCX 3,495 $0 0 $0 0 $0

Yearly summary of insider trading at Etelos, Inc. (ETLO) by Levine Mitchell S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 ETLO 4,436,111 $1,109,027 0 $0 0 $0
2010 ETLO 0 $0 43,200 $28,643 0 $0
2009 ETLO 0 $0 234,400 $190,076 0 $0
2008 ETLO 0 $0 112,650 $638,639 0 $0


Insider trading activities at 2 companies by Levine Mitchell S:

1. Oncocyte Corp (OCX)

2. Etelos, Inc. (ETLO)

Table 1. Insider trading of Oncocyte Corp (OCX) by Levine Mitchell S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-15 OCX Buy 25,000 1.17 29,149
2021-04-28 OCX Option Ex 20,000 .00 0
2020-08-03 OCX Buy 10,000 1.32 13,200
2020-03-14 OCX Option Ex 20,000 .00 0
2019-09-12 OCX Buy 10,000 2.01 20,059
2018-07-26 OCX Buy 3,495 .00 0

Table 2. Insider trading of Etelos, Inc. (ETLO) by Levine Mitchell S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-12-31 ETLO Buy 4,436,111 .25 1,109,027
2010-01-12 ETLO Sale 15,000 .60 9,000
2010-01-11 ETLO Sale 9,500 .67 6,365
2010-01-08 ETLO Sale 14,000 .70 9,800
2010-01-07 ETLO Sale 4,700 .74 3,478
2009-11-06 ETLO Sale 5,000 1.00 5,000
2009-11-04 ETLO Sale 15,000 .96 14,355
2009-10-29 ETLO Sale 6,200 .80 4,960
2009-10-30 ETLO Sale 40,000 .83 33,240
2009-10-12 ETLO Sale 10,000 .80 8,000
2009-10-07 ETLO Sale 29,500 .65 19,175
2009-10-06 ETLO Sale 17,250 .56 9,660
2009-10-05 ETLO Sale 10,300 .55 5,665
2009-10-02 ETLO Sale 25,000 .32 8,000
2009-05-15 ETLO Sale 2,000 1.10 2,200
2009-05-13 ETLO Sale 5,000 1.10 5,500
2009-05-07 ETLO Sale 25,700 1.05 27,062
2009-05-08 ETLO Sale 2,950 1.15 3,392
2009-05-06 ETLO Sale 4,000 1.14 4,560
2009-05-05 ETLO Sale 3,000 1.14 3,419
2009-05-01 ETLO Sale 3,000 1.14 3,419
2009-04-14 ETLO Sale 500 1.15 575
2009-04-07 ETLO Sale 4,200 1.20 5,040
2009-03-24 ETLO Sale 3,687 1.20 4,424
2009-03-25 ETLO Sale 1,500 1.20 1,800
2009-03-23 ETLO Sale 800 1.15 919
2009-03-17 ETLO Sale 513 1.15 589
2009-03-11 ETLO Sale 500 1.05 525
2009-03-09 ETLO Sale 300 1.05 315
2009-03-05 ETLO Sale 12,000 1.01 12,107
2009-03-04 ETLO Sale 6,000 .95 5,700
2009-03-03 ETLO Sale 500 .95 475
2008-08-06 ETLO Sale 5,000 6.00 30,000
2008-08-06 ETLO Sale 5,000 6.00 30,000
2008-08-01 ETLO Sale 2,000 7.00 14,000
2008-07-28 ETLO Sale 10,000 7.25 72,520
2008-07-29 ETLO Sale 1,100 6.92 7,609
2008-07-24 ETLO Sale 5,000 7.50 37,500
2008-07-16 ETLO Sale 300 14.00 4,200
2008-07-15 ETLO Sale 8,500 12.41 105,493
2008-07-14 ETLO Sale 3,200 11.00 35,200
2008-07-09 ETLO Sale 5,500 7.07 38,874
2008-07-11 ETLO Sale 3,400 9.91 33,697
2008-07-10 ETLO Sale 1,350 8.81 11,898
2008-07-07 ETLO Sale 1,000 6.50 6,500
2008-07-02 ETLO Sale 1,000 5.50 5,500
2008-07-03 ETLO Sale 5,000 6.00 30,000
2008-06-30 ETLO Sale 1,000 4.50 4,500
2008-06-27 ETLO Sale 5,000 4.00 20,000
2008-07-01 ETLO Sale 1,000 4.75 4,750
2008-05-28 ETLO Sale 3,000 3.50 10,500
2008-05-30 ETLO Sale 35,000 3.00 105,000
2008-05-02 ETLO Sale 6,700 3.05 20,448
2008-05-05 ETLO Sale 1,600 4.50 7,200
2008-05-01 ETLO Sale 500 2.00 1,000
2008-04-30 ETLO Sale 1,500 1.50 2,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levine Mitchell S (Chief Financial Officer of Oncocyte Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.